Top 5 Takeaways Lower Incidence with Masks: Districts with universal mask requirements had a 23% lower incidence of COVID-19 among staff and students compared to those without mask mandates. Impact
Tag: 2022
Top 5 Takeaways Full FDA Approval: On January 31, 2022, the FDA granted full approval to the Moderna COVID-19 vaccine for individuals aged ≥18 years. ACIP Recommendation: On February 4,
Top 5 Takeaways High Provider Accessibility: By 11 weeks after the pediatric COVID-19 vaccination program launch, 92% of children aged 5–11 years lived within 5 miles of a vaccine provider.
Top 5 Takeaways High Adverse Event Rate: 91.4% of patients reported experiencing at least one adverse event during treatment with nifurtimox. Demographic Concentration: Most patients were adults aged ≥18 years
Top 5 Takeaways High Specificity: The study found that the specificity of DENV and SARS-CoV-2 enzyme-linked immunosorbent assays (ELISAs) was ≥98%, indicating minimal cross-reactivity. Minimal Cross-Reactivity: Results showed minimal levels
Top 5 Takeaways Low Vaccine Effectiveness: The 2021–22 seasonal influenza vaccine showed only 16% effectiveness against medically attended outpatient ARI caused by influenza A(H3N2) viruses. Predominance of A(H3N2): Most influenza
Top 5 Takeaways Increased Hospitalization Rates: During the Omicron variant predominance, infants and children aged 0–4 years were hospitalized at approximately five times the rate compared to the Delta variant
Top 5 Takeaways Vaccine Effectiveness: Two doses of the Pfizer-BioNTech COVID-19 vaccine reduced the risk of Omicron infection by 31% among children aged 5–11 years and by 59% among adolescents
Top 5 Takeaways Significant Reduction in Cases: From 2000 to 2020, reported neonatal tetanus cases decreased by 88%, and estimated deaths declined by 92% globally. Progress in Elimination: 47 out
Top 5 Takeaways Significant Increase in ESKD Cases: From 2000 to 2019, the number of incident ESKD cases in the U.S. increased by 41.8%, while the number of prevalent cases